GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of US.
https://www.reportscorner.com/reports/21521/CountryFocus:-Healthcare,-Regulatory-and-Reimbursement-Landscape---US/
2. DescriptionDescription
Reports Cornerwww.reportscorner.com
GlobalData, the industry analysis specialist, has released its new
report, “CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape - US”. The report is an essential
source of information and analysis on the healthcare, regulatory
and reimbursement landscape of US.
3. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
CountryFocus: Healthcare, Regulatory and Reimbursement
Landscape - US
Summary
GlobalData, the industry analysis specialist, has released its new
report, “CountryFocus: Healthcare, Regulatory and
Reimbursement Landscape - US”. The report is an essential
source of information and analysis on the healthcare, regulatory
and reimbursement landscape of US. The report identifies the key
trends in the healthcare market of US. The report also provides
insights on the demographic, regulatory, reimbursement
landscape and healthcare infrastructure of US. Most importantly,
the report provides valuable insights on the trends and
segmentation of the pharmaceutical and medical devices market.
4. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
This report is built using data and information sourced from
proprietary databases, secondary research and in-house analysis
by GlobalData's team of industry experts.
In 2012, US was the third most populated country in the world
with a population of approximately 316.2 million. The population
of US is increasing at a slow rate of growth due to a negative
balance between the mortality and birth rate and low fertility rate.
The decline in the population of the working age group and the
increasing elderly population are matters of concern for US policy
planners. The pharmaceutical market in US was estimated at
approximately $359 billion in 2012 and is expected to reach
approximately $475 billion by 2020, with a projected CAGR of
3.5%. The medical device market size was approximately $138.9
billion in 2012 and is expected to reach approximately $206 billion
by 2020, at a projected CAGR of 5.1%.
5. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
Scope
The report provides information on the healthcare, regulatory and
reimbursement landscape of US. The scope of the report includes
-
- An overview of the pharmaceutical and medical devices market
of US including the market size, market segmentation, key drivers
and barriers for the market.
- Profiles and SWOT analyses of the major players in the
pharmaceutical and medical devices market. Key players covered
in the pharmaceutical market are Pfizer, Merck & Co., Roche,
Abbott and Novartis. Key players covered for the medical devices
market are Medtronic, Boston Scientific, Abbott, GlaxoSmithKline
and Siemens Healthcare.
6. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- An insightful review on the reimbursement and regulatory
landscape. Analysis includes details of the healthcare
reimbursement process, regulatory agencies and market
authorization processes for new drug and medical devices for US.
- A detailed analysis of the political and economic environment of
US, including economic indicators, demographics, healthcare
infrastructure and healthcare expenditure.
- An overview of the opportunities and challenges for growth that
exist in the healthcare market of US.
Reasons to buy
The report on US comprehensively covers both the
pharmaceutical and medical devices markets of US. The report
will enhance your decision-making capability. It will allow you to -
- Develop business strategies by understanding the trends
shaping and driving the healthcare market of US.
7. Brief SummaryBrief Summary
Reports Cornerwww.reportscorner.com
- Drive revenues by understanding the key trends, reimbursement
and regulatory policies, pharmaceutical and medical devices
market segments and companies likely to impact US healthcare
market in the future.
- Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analyzing the
performance of various competitors.
- Organize your sales and marketing efforts by identifying the
market categories and segments that present the greatest
opportunities for consolidations, investments and strategic
partnerships.
- Identify, understand and capitalize on the opportunities and
challenges in the healthcare market of US.
8. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 19
2.1 Report Guidance 19
3 Overview of the Pharmaceutical and Medical Device Markets 20
3.1 Pharmaceutical Market 20
3.1.1 Market Overview 20
3.1.2 Supply Channels 27
3.1.3 Market Segments 30
3.1.4 Overview of Major Disease Segments 46
3.1.5 Major Players 50
3.2 Medical Device Market 105
3.2.1 Market Overview 105
9. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
3.2.2 Overview of Top Five Segments 107
3.2.3 Diagnostic Market 118
3.2.4 Major Players 120
3.3 Market Drivers and Barriers 158
3.3.1 Drivers 158
3.3.2 Barriers 160
4 Market Access 165
4.1.1 Reimbursement and Payer Landscape 165
4.1.2 Health Insurance and Managed Care in US 166
4.1.3 Overview of Insurance Providers 171
4.1.4 Patient Share in Healthcare Spending 184
4.1.5 Prescription Drug Price Trend 186
4.1.6 Pricing Policies 187
4.2 Regulatory Landscape 190
4.2.1 Overview of Regulatory Agencies 190
10. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
4.2.2 New Drug Approval Process 191
4.2.3 Approval Process of Biological Products as Biosimilar or Interchangeable 208
4.2.4 New Medical Device Approval Process 209
4.2.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 217
4.2.6 Licensing Process for Pharmaceutical Exports and Imports 222
4.2.7 Intellectual Property Rights 236
4.2.8 Clinical Trial Regulations 239
4.2.9 Pharmaceutical Advertising Regulations 244
4.2.10 Pharmacy Regulations 245
4.2.11 Labeling and Packaging Regulations 247
5 Country Analysis 250
5.1 Political Environment 250
5.1.1 Political Structure 250
5.1.2 Analysis of Current Political Environment 251
5.1.3 Healthcare Policy Initiatives 254
11. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
5.2 Economic Landscape 259
5.3 Economic Indicators 265
5.3.1 Gross Domestic Product 265
5.3.2 Gross National Income 269
5.3.3 Inflation 270
5.3.4 Currency Exchange Rate 273
5.3.5 Foreign Direct Investment 276
5.3.6 Foreign Exchange Reserves 277
5.3.7 Trade Balance 278
5.3.8 Government Structural Balance 281
5.3.9 Government Net Debt 283
5.3.10 Major Industries 285
5.4 Demography 286
5.4.1 Population 286
5.4.2 Education and Literacy 303
12. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
5.4.3 Employment 305
5.4.4 Disease Burden 307
5.5 Healthcare Infrastructure 310
5.5.1 Healthcare Facilities 310
5.5.2 Healthcare Parameters 318
5.5.3 Environmental Health 322
5.5.4 Healthcare Personnel 327
5.6 Healthcare Expenditure 328
5.6.1 Overview 328
5.6.2 Major Components of Healthcare Spending 329
5.6.3 Share of Public and Private Sectors 331
5.6.4 Spending in Pharmaceutical R&D 332
5.7 Trade Associations 334
5.7.1 Pharmaceutical Research and Manufacturers of America 334
5.7.2 Consumer Healthcare Products Association 334
13. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
5.7.3 International Pharmaceutical Excipients Council 334
5.7.4 Advanced Medical Technology Association 335
5.7.5 National Association for Home Care & Hospices 335
5.7.6 Biotech Industry Association 335
5.7.7 The Society of Chemical Manufacturers and Affiliates 336
5.8 Trade Fairs 336
6 Opportunities and Challenges 339
6.1 Opportunities 339
6.2 Challenges 341
7 Appendix 344
7.1 Abbreviations 344
7.2 Bibliography 353
7.3 Methodology 369
7.3.1 Coverage 369
7.3.2 Secondary Research 369
14. Table of ContentsTable of Contents
Reports Cornerwww.reportscorner.com
7.3.3 Forecasting 370
7.3.4 Expert Panel Validation 370
7.4 Contact Us 370
7.5 Disclaimer 371
15. For more informationFor more information
Reports Cornerwww.reportscorner.com
For more information please visit our website
https://www.reportscorner.com/reports/21521/CountryFocus:-Healthcare,-
Regulatory-and-Reimbursement-Landscape---US/
